Researchers hope to have 15,000 participants enrolled in the Phase 3 trial of the Moderna Covid-19 vaccine by the end of the week, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said during a call with reporters on Monday.
“I'm not sure that we're going to get there, but hopefully we'll get as many as we possibly can in order to keep our timeline the way we want it to be,” he said.
The first dose of a vaccine candidate in the Phase 3 trial took place Monday morning in Savannah, Georgia. The trial is expected to enroll about 30,000 adult volunteers.
The start of Moderna’s Phase 3 vaccine candidate trial on Monday is “the best we in the United States have ever done,” Fauci said.
Fauci said it took 62 days from the time the virus sequence was made publicly available for Moderna to start a Phase 1 trial.
“And now six months later, we’re beginning a Phase 3 trial,” Fauci said.